Literature DB >> 7903159

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

F Powrie1, M W Leach, S Mauze, L B Caddle, R L Coffman.   

Abstract

CD4+ T cells in the mouse can be subdivided into two fractions based on the level of expression of the CD45RB determinant. Previous studies have shown that these subsets are functionally distinct. We have further characterized the properties of these subpopulations in vivo by injecting them into C. B-17 scid mice. The animals restored with the CD45RBhighCD4+ T cell population developed a lethal wasting disease with severe mononuclear cell infiltrates into the colon and elevated levels of IFN-gamma mRNA. In contrast, animals restored with the reciprocal CD45RBlow subset or with unfractionated CD4+ T cells did not develop the wasting or colitis. Importantly, the co-transfer of the CD45RBlow population with the CD45RBhigh population prevented the wasting disease and colitis. These data indicate that important regulatory interactions occur between the CD45RBhigh and CD45RBlowCD4+ T cell subsets and that disruption of this mechanism has fatal consequences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903159     DOI: 10.1093/intimm/5.11.1461

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  371 in total

1.  Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

Authors:  M M Kosiewicz; C C Nast; A Krishnan; J Rivera-Nieves; C A Moskaluk; S Matsumoto; K Kozaiwa; F Cominelli
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.

Authors:  W Strober; K Nakamura; A Kitani
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 3.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

Review 4.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 5.  Control of immune pathology by IL-10-secreting regulatory T cells.

Authors:  S Fowler; F Powrie
Journal:  Springer Semin Immunopathol       Date:  1999

Review 6.  T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling.

Authors:  G F Hoyne; M J Dallman; J R Lamb
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

Review 7.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

8.  CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Authors:  Yu-Hwa Huang; Chen Zhu; Yasuyuki Kondo; Ana C Anderson; Amit Gandhi; Andrew Russell; Stephanie K Dougan; Britt-Sabina Petersen; Espen Melum; Thomas Pertel; Kiera L Clayton; Monika Raab; Qiang Chen; Nicole Beauchemin; Paul J Yazaki; Michal Pyzik; Mario A Ostrowski; Jonathan N Glickman; Christopher E Rudd; Hidde L Ploegh; Andre Franke; Gregory A Petsko; Vijay K Kuchroo; Richard S Blumberg
Journal:  Nature       Date:  2014-10-26       Impact factor: 49.962

9.  Ceramide synthesis regulates T cell activity and GVHD development.

Authors:  M Hanief Sofi; Jessica Heinrichs; Mohammed Dany; Hung Nguyen; Min Dai; David Bastian; Steven Schutt; Yongxia Wu; Anusara Daenthanasanmak; Salih Gencer; Aleksandra Zivkovic; Zdzislaw Szulc; Holger Stark; Chen Liu; Ying-Jun Chang; Besim Ogretmen; Xue-Zhong Yu
Journal:  JCI Insight       Date:  2017-05-18

10.  High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis.

Authors:  X Ma; M Torbenson; A R A Hamad; M J Soloski; Z Li
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.